PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-270
Closed -$7.82K 516
2025
Q4
$7.82K Buy
270
+222
+463% +$6.66K ﹤0.01% 426
2025
Q3
$1.33K Hold
48
﹤0.01% 498
2025
Q2
$1.17K Hold
48
﹤0.01% 454
2025
Q1
$996 Hold
48
﹤0.01% 440
2024
Q4
$1.13K Hold
48
﹤0.01% 434
2024
Q3
$1.23K Hold
48
﹤0.01% 337
2024
Q2
$1.13K Sell
48
-428
-90% -$10.8K ﹤0.01% 327
2024
Q1
$13.7K Hold
476
0.01% 264
2023
Q4
$15.6K Buy
476
+208
+78% +$5.66K 0.01% 234
2023
Q3
$7.47K Hold
268
0.01% 213
2023
Q2
$9.14K Hold
268
0.01% 207
2023
Q1
$8.06K Hold
268
0.01% 224
2022
Q4
$7.57K Buy
+268
New +$8.51K 0.01% 217

Other funds holding ARKG

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s ARKG Position: Q1 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2026, closing a stake of 270 shares — an estimated $7.82K sold.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in ARKG in Q4 2022 and held it in 13 quarters. The position peaked at $15.6K in Q4 2023. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. reported no remaining ARK Genomic Revolution ETF position as of Q1 2026 after selling out during the quarter.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. sold 270 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $7.82K.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in ARK Genomic Revolution ETF in Q4 2022 and held it in 13 quarters.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s ARK Genomic Revolution ETF position peaked at $15.6K in Q4 2023.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q1 2026, filed 7 Aug 2026.